The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
all of these advances are converging in a way that if we keep talking at fouryear increments the pace of progress is going to be like substantially greater per unit time we've already witnessed that I mean it's there's no question that fouryear increments over my career that's that's been true um it's reflected just in in approval of drugs by the FDA uh for cancer but but now the convergence of Diagnostics and Therapeutics — that's what's finally coming into view
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
all of these advances are converging in a way that if we keep talking at fouryear increments the pace of progress is going to be like substantially greater per unit time we've already witnessed that I mean it's there's no question that fouryear increments over my career that's that's been true um it's reflected just in in approval of drugs by the FDA uh for cancer but but now the convergence of Diagnostics and Therapeutics um that's what's finally coming into view um that that that that piece has really I would say been largely missing